Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 2
1979 1
1981 2
1982 2
1983 3
1984 3
1985 4
1986 3
1987 5
1988 3
1989 3
1990 6
1991 4
1992 6
1993 6
1994 5
1995 6
1996 5
1997 3
1998 6
1999 7
2000 4
2001 10
2002 8
2003 6
2004 12
2005 15
2006 8
2007 10
2008 7
2009 2
2010 5
2011 9
2012 4
2013 5
2014 4
2015 6
2016 5
2017 6
2018 6
2019 3
2020 8
2021 10
2022 8
2023 8
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Progression of antibiotic resistance in Neisseria meningitidis.
Rodriguez E, Tzeng Y-L, Berry I, Howie R, McNamara L, Stephens DS. Rodriguez E, et al. Among authors: stephens ds. Clin Microbiol Rev. 2025 Mar 13;38(1):e0021524. doi: 10.1128/cmr.00215-24. Epub 2025 Jan 31. Clin Microbiol Rev. 2025. PMID: 39887238 Review.
Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae.
Wu X, Alibayov B, Xiang X, Lattar SM, Sakai F, Medders AA, Antezana BS, Keller LE, Vidal AGJ, Tzeng YL, Robinson DA, Stephens DS, Yu Y, Vidal JE. Wu X, et al. Among authors: stephens ds. Drug Resist Updat. 2024 Nov;77:101138. doi: 10.1016/j.drup.2024.101138. Epub 2024 Aug 16. Drug Resist Updat. 2024. PMID: 39167981 Free article.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH; COVAIL Study Group. Branche AR, et al. Among authors: stephens ds. Nat Med. 2023 Sep;29(9):2334-2346. doi: 10.1038/s41591-023-02503-4. Epub 2023 Aug 28. Nat Med. 2023. PMID: 37640860 Free PMC article. Clinical Trial.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
Lyke KE, Atmar RL, Dominguez Islas C, Posavad CM, Deming ME, Branche AR, Johnston C, El Sahly HM, Edupuganti S, Mulligan MJ, Jackson LA, Rupp RE, Rostad CA, Coler RN, Bäcker M, Kottkamp AC, Babu TM, Dobrzynski D, Martin JM, Brady RC, Frenck RW Jr, Rajakumar K, Kotloff K, Rouphael N, Szydlo D, PaulChoudhury R, Archer JI, Crandon S, Ingersoll B, Eaton A, Brown ER, McElrath MJ, Neuzil KM, Stephens DS, Post DJ, Lin BC, Serebryannyy L, Beigel JH, Montefiori DC, Roberts PC; DMID 21-0012 Study Group. Lyke KE, et al. Among authors: stephens ds. NPJ Vaccines. 2023 Jul 11;8(1):98. doi: 10.1038/s41541-023-00693-z. NPJ Vaccines. 2023. PMID: 37433788 Free PMC article.
Global Control of Meningococcal Disease.
Stephens DS. Stephens DS. N Engl J Med. 2023 May 25;388(21):2003-2005. doi: 10.1056/NEJMe2301698. N Engl J Med. 2023. PMID: 37224203 No abstract available.
247 results